COVID-19 Vaccination in Kidney Transplant Candidates and Recipients
Open Access
Abstract
Kidney transplant candidates and kidney transplant recipients (KTRs) are at particular risk of severe complications of COVID-19 disease. In Western countries, mortality in affected hospitalized KTRs ranges between 19% and 50%. COVID-19 vaccination remains the most important measure to prevent the severity of infection in candidates and recipients of kidney transplant. However, the uraemic condition may affect the vaccine-induced immunity in patients with advanced chronic kidney disease (CKD) and in KTRs. Retention of uraemic toxins, dysbiosis, dysmetabolism, and dialysis can diminish the normal response to vaccination, leading to dysfunction of inflammatory and immune cells. In KTRs the efficacy of vaccines may be reduced by the immunosuppressive medications, and more than half of kidney transplant recipients are unable to build an immune response even after four administrations of anti-COVID-19 vaccines. The lack of antibody response leaves these patients at high risk for SARS-CoV-2 infection and severe COVID-19 disease. The aim of the present review is to focus on the main reasons for the impaired immunological response among candidates and kidney transplant recipients and to highlight some of the present options available to solve the problem.Keywords
This publication has 163 references indexed in Scilit:
- Vitamin D and Immune FunctionNutrients, 2013
- The intestinal microbiota, a leaky gut, and abnormal immunity in kidney diseaseKidney International, 2013
- Irreversible Renal Damage after Transient Renin-Angiotensin System Stimulation: Involvement of an AT1-Receptor Mediated Immune ResponsePLOS ONE, 2013
- Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipientsTransplant Infectious Disease, 2012
- Antibody response to the non‐adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipientsTransplant Infectious Disease, 2012
- De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2011
- Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine productionNephrology Dialysis Transplantation, 2009
- The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cellsNephrology Dialysis Transplantation, 2005
- Phagocytic Polymorphonuclear Function in Patients with Progressive Uremia and the Effect of Acute HemodialysisRenal Failure, 2005
- Cell apoptosis and hemodialysis-induced inflammationKidney International, 2002